Please contact your representative at Oppenheimer & Co to request a 1-on ... of the author and do not necessarily reflect those of Nasdaq, Inc. Sign up for our newsletter to get the latest on ...

MongoDB (NASDAQ:MDB – Free Report) had its price target reduced by Oppenheimer from $400.00 to $330.00 in a research report ...

CINCINNATI--(BUSINESS WIRE)-- Chemed Corporation (NYSE:CHE) today announced that it will deliver a virtual presentation at the Oppenheimer ... reflect those of Nasdaq, Inc. Sign up for our ...

As of March 4, 2025, the average one-year price target for Abeona Therapeutics is $16.22/share. The forecasts range from a low of $9.60 to a high of $22.05. The average price target represents an ...

Oppenheimer & Co. Inc. raised its stake in First Trust BuyWrite Income ETF (NASDAQ:FTHI – Free Report) by 17.3% during the 4th quarter, Holdings Channel reports. The fund owned 11,818 shares of the ...

Proficio Capital Partners LLC bought a new stake in shares of Jack in the Box Inc. (NASDAQ:JACK – Free Report) in the fourth ...

D. Boral Capital reissued their buy rating on shares of Trevi Therapeutics (NASDAQ:TRVI – Free Report) in a research note ...

Oppenheimer Asset Management Inc. acquired a new stake in shares of Texas Capital Bancshares, Inc. (NASDAQ:TCBI – Free Report ...

Bioceres Crop Solutions Corp. (NASDAQ:BIOX – Get Free Report) has been given a consensus rating of “Buy” by the six ratings ...

StockNews.com lowered shares of Universal Display (NASDAQ:OLED – Free Report) from a hold rating to a sell rating in a report ...

Shares of AppLovin Co. (NASDAQ:APP – Get Free Report) have been given an average recommendation of “Moderate Buy” by the twenty research firms that are covering the company, Marketbeat.com reports.

Shares of Remitly Global, Inc. (NASDAQ:RELY – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from ...